A Randomized Double-blinded Trial to Explore the Optimum Dose of Tranexamic Acid in Cardiopulmonary Bypass Cardiac Surgery
Phase of Trial: Phase IV
Latest Information Update: 28 Feb 2016
Price : $35 *
At a glance
- Drugs Tranexamic acid (Primary)
- Indications Postoperative haemorrhage
- Focus Therapeutic Use
- 16 Sep 2014 Status changed from recruiting to completed, as per ClinicalTrials.gov record.
- 29 Jul 2014 Planned primary completion date changed from 1 Dec 2013 to 1 Aug 2014, as per ClinicalTrials.gov record.
- 06 Dec 2013 New trial record